Production and synthesis of a novel Pt-labeled platinum complex and evaluation of its biodistribution in healthy mice

面川 真里奈*; 木村 寛之*; 初川 雄一*; 河嶋 秀和*; 塚田 和明; 屋木 祐介*; 内藤 行基*; 安井 裕之*

Bioorganic & Medicinal Chemistry, 97, p.117557_1 - 117557_6, 2024/01

https://doi.org/10.1016/j.bmc.2023.117557

Pt was produced via the (n,2n) reaction induced by accelerator neutrons. [Pt]FGC-Pt was obtained through the accelerator neutron irradiation of FGC-Pt and KPtCl. Highly purified [Pt]FGC-Pt was obtained using the latter method, which suggests that the synthetic method using a Pt-labeled platinum reagent is suitable for the radioactivation of platinum complexes. We also investigated whether a significant correlation existed between the biodistribution of FGC-Pt and [Pt]FGC-Pt in healthy mice 24 h after tail vein administration. These results suggest that Pt-labeled compounds, synthesized using radioactive platinum reagents, can be used to confirm the biodistribution of platinum compounds. Our study on the biodistribution of [Pt]FGC-Pt is expected to contribute to the development of novel platinum-based drugs in the future.